
hVIVO achieves record revenue, up 30% YoY to £50.6 million
hVIVO plc (LON:HVO) (formerly Open Orphan plc), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced